{
    "id": 22988,
    "fullName": "TP53 D259Y",
    "impact": "missense",
    "proteinEffect": "unknown",
    "geneVariantDescriptions": [
        {
            "description": "TP53 D259Y lies within the DNA-binding domain of the Tp53 protein (PMID: 21760703). D259Y has been identified in the scientific literature (PMID: 22550420, PMID: 28751246, PMID: 27859003), but has not been biochemically characterized and therefore, its effect on Tp53 protein function is unknown (PubMed, Oct 2019).",
            "references": [
                {
                    "id": 14778,
                    "pubMedId": 28751246,
                    "title": "Concordance between Comprehensive Cancer Genome Profiling in Plasma and Tumor Specimens.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/28751246"
                },
                {
                    "id": 7929,
                    "pubMedId": 27859003,
                    "title": "Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK/STAT signalling pathway genes, TP53 and DNMT3A.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27859003"
                },
                {
                    "id": 285,
                    "pubMedId": null,
                    "title": null,
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed"
                },
                {
                    "id": 807,
                    "pubMedId": 21760703,
                    "title": "TP53 status and response to treatment in breast cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21760703"
                },
                {
                    "id": 7928,
                    "pubMedId": 22550420,
                    "title": "Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/22550420"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 7157,
        "geneSymbol": "TP53",
        "terms": [
            "TP53",
            "BCC7",
            "BMFS5",
            "LFS1",
            "P53",
            "TRP53"
        ]
    },
    "variant": "D259Y",
    "createDate": "05/28/2016",
    "updateDate": "10/15/2019",
    "referenceTranscriptCoordinates": {
        "id": 94097,
        "transcript": "NM_000546",
        "gDna": "chr17:g.7674188C>A",
        "cDna": "c.775G>T",
        "protein": "p.D259Y",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6607,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Selumetinib (AZD6244) inhibited proliferation of human melanoma cells harboring TP53 D259Y in culture (PMID: 26343583).",
            "molecularProfile": {
                "id": 23639,
                "profileName": "TP53 D259Y"
            },
            "therapy": {
                "id": 913,
                "therapyName": "Selumetinib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5709,
                    "pubMedId": 26343583,
                    "title": "Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26343583"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6608,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Zelboraf (vemurafenib) inhibited proliferation of human melanoma cells TP53 D259Y in culture (PMID: 26343583).",
            "molecularProfile": {
                "id": 23639,
                "profileName": "TP53 D259Y"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5709,
                    "pubMedId": 26343583,
                    "title": "Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26343583"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6595,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY3009120 modestly inhibited soft agar growth of human melanoma cancer cells harboring TP53 D259Y in culture (PMID: 26343583).",
            "molecularProfile": {
                "id": 23639,
                "profileName": "TP53 D259Y"
            },
            "therapy": {
                "id": 3268,
                "therapyName": "LY3009120",
                "synonyms": null
            },
            "indication": {
                "id": 1909,
                "name": "melanoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 5709,
                    "pubMedId": 26343583,
                    "title": "Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26343583"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 23639,
            "profileName": "TP53 D259Y",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 94097,
            "transcript": "NM_000546",
            "gDna": "chr17:g.7674188C>A",
            "cDna": "c.775G>T",
            "protein": "p.D259Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94098,
            "transcript": "NM_001126113",
            "gDna": "chr17:g.7674188C>A",
            "cDna": "c.775G>T",
            "protein": "p.D259Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94100,
            "transcript": "NM_001126115",
            "gDna": "chr17:g.7669620C>A",
            "cDna": "c.775G>T",
            "protein": "p.D259Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94096,
            "transcript": "NM_001126112",
            "gDna": "chr17:g.7674188C>A",
            "cDna": "c.775G>T",
            "protein": "p.D259Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 94099,
            "transcript": "NM_001126114",
            "gDna": "chr17:g.7674188C>A",
            "cDna": "c.775G>T",
            "protein": "p.D259Y",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}